Oncogene

Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours.

Oncogene

Rajan N, Elliott R, Clewes O, Mackay A, Reis-Filho JS, Burn J, Langtry J, Sieber-Blum M, Lord CJ, Ashworth A

Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer.

Oncogene

Bu W, Chen J, Morrison GD, Huang S, Creighton CJ, Huang J, Chamness GC, Hilsenbeck SG, Roop DR, Leavitt AD, Li Y

Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer.

Oncogene

Bu W, Chen J, Morrison GD, Huang S, Creighton CJ, Huang J, Chamness GC, Hilsenbeck SG, Roop DR, Leavitt AD, Li Y

Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation.

Oncogene

Wheeler SE, Suzuki S, Thomas SM, Sen M, Leeman-Neill RJ, Chiosea SI, Kuan CT, Bigner DD, Gooding WE, Lai SY, Grandis JR

Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation.

Oncogene

Wheeler SE, Suzuki S, Thomas SM, Sen M, Leeman-Neill RJ, Chiosea SI, Kuan CT, Bigner DD, Gooding WE, Lai SY, Grandis JR

Presenilin modulates EGFR signaling and cell transformation by regulating the ubiquitin ligase Fbw7.

Oncogene

Rocher-Ros V, Marco S, Mao JH, Gines S, Metzger D, Chambon P, Balmain A, Saura CA

Presenilin modulates EGFR signaling and cell transformation by regulating the ubiquitin ligase Fbw7.

Oncogene

Rocher-Ros V, Marco S, Mao JH, Gines S, Metzger D, Chambon P, Balmain A, Saura CA

An HDAC1-binding domain within FATS bridges p21 turnover to radiation-induced tumorigenesis.

Oncogene

Li Z, Zhang Q, Mao JH, Weise A, Mrasek K, Fan X, Zhang X, Liehr T, Lu KH, Balmain A, Cai WW

Pages